EW250516C42500
- 0.00
- 0.000.00%
Edwards Lifesciences Newsroom
Jefferies Maintains Edwards Lifesciences(EW.US) With Hold Rating
Jefferies Remains a Hold on Edwards Lifesciences (EW)
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Gilead Sciences (GILD)
CCORF Maintains Edwards Lifesciences(EW.US) With Hold Rating, Raises Target Price to $75
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $75 to $90
Hold Rating on Edwards Lifesciences: Balancing Positive Trends With TAVR Uncertainties
Bernstein Adjusts Price Target on Edwards Lifesciences to $80 From $78
Research Alert: Ew Reports Q1 Results, Posting Strong Operating Margins
Edwards Lifesciences Is Maintained at Neutral by Baird
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Resmed (RMD) and Thermo Fisher (TMO)
Edwards Lifesciences Analyst Ratings
Piper Sandler Upgrades Edwards Lifesciences(EW.US) to Buy Rating, Raises Target Price to $80
TD Cowen Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $75
Edwards Lifesciences: Hold Rating Amid Strong Q1 Results and Future Challenges
Stifel Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Edwards Lifesciences (EW) Gets a Buy From Stifel Nicolaus
Barclays Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), UnitedHealth (UNH) and Edwards Lifesciences (EW)
Leerink Partners Maintains Edwards Lifesciences(EW.US) With Hold Rating, Announces Target Price $77
Leerink Partners Maintains Edwards Lifesciences(EW.US) With Hold Rating